Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 187 publications
Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.
Journal: JCO precision oncology
Published: July 15, 2026
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into Response.
Journal: JCO precision oncology
Published: June 03, 2026
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.
Journal: The New England journal of medicine
Published: June 01, 2026
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2026
Durvalumab with Gemcitabine and Oxaliplatin in Advanced Biliary Tract Cancer.
Journal: Cancers
Published: May 05, 2026
Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 26, 2026
Electrophoretic deposition of TiO2 doped amine-grafted mesoporous bioactive glass on 3D-printed poly(L-lactic acid)/reduced graphene oxide scaffolds for bone tissue regeneration.
Journal: International journal of biological macromolecules
Published: January 02, 2026
Oncogene Mutations: The Shared Antigen Vaccines That Work?
Journal: Annual review of medicine
Published: December 05, 2025
Impact of Tumor Multifocality on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma: Implications for Future Staging Systems.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: December 05, 2025
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01.
Journal: JAMA oncology
Published: November 20, 2025
Phase I results of a multicenter, open-label, dose de-escalation and expansion study of gemcitabine and cisplatin with ivosidenib or pemigatinib for advanced cholangiocarcinoma.
Journal: Investigational new drugs
Published: November 12, 2025
Last Updated: 09/26/2026